HYPOVOLEMIC SHOCK

Clinical trials for HYPOVOLEMIC SHOCK explained in plain language.

Never miss a new study

Get alerted when new HYPOVOLEMIC SHOCK trials appear

Sign up with your email to follow new studies for HYPOVOLEMIC SHOCK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug could save lives from shock after severe bleeding

Disease control Recruiting now

This study tests a new drug called LYFAQUIN (centhaquine) for people in hypovolemic shock, a life-threatening condition caused by severe blood or fluid loss. The drug aims to help restore blood pressure and improve survival when used alongside standard treatments. About 400 adult…

Matched conditions: HYPOVOLEMIC SHOCK

Phase: PHASE4 • Sponsor: Pharmazz, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC

HYPOVOLEMIC SHOCK

Get alerted when new HYPOVOLEMIC SHOCK trials appear

New drug could save lives from shock after severe bleeding